1. Home
  2. ALM vs COGT Comparison

ALM vs COGT Comparison

Compare ALM & COGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Almonty Industries Inc.

ALM

Almonty Industries Inc.

HOLD

Current Price

$13.89

Market Cap

5.5B

ML Signal

HOLD

Logo Cogent Biosciences Inc.

COGT

Cogent Biosciences Inc.

HOLD

Current Price

$31.65

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALM
COGT
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
6.1B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
ALM
COGT
Price
$13.89
$31.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
15
Target Price
$22.33
$36.21
AVG Volume (30 Days)
5.9M
1.5M
Earning Date
05-20-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$7,871,000.00
Revenue This Year
$817.94
N/A
Revenue Next Year
$158.05
$1,733.58
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.24
$11.61
52 Week High
$24.41
$43.73

Technical Indicators

Market Signals
Indicator
ALM
COGT
Relative Strength Index (RSI) 38.97 31.56
Support Level $12.47 $30.90
Resistance Level $14.92 $37.69
Average True Range (ATR) 1.19 1.25
MACD -0.58 -0.16
Stochastic Oscillator 8.55 9.59

Price Performance

Historical Comparison
ALM
COGT

About ALM Almonty Industries Inc.

Almonty Industries Inc is engaged in the development of the Sangdong Mine in South Korea, and the Company is currently mining, processing, and shipping tungsten concentrate from the Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal (Panasqueira Mine). Additionally, the Company is evaluating its molybdenum project with inferred mineral resources on a separate property adjacent to the tungsten orebody at the Sangdong Mine, its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora (Valtreixal Mine), and the newly-acquired Gentung Browns Lake tungsten project located in Montana, USA (Gentung-Browns Lake Project). The company has two geographical locations: the Iberian Peninsula (Spain and Portugal) and the Republic of Korea.

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Share on Social Networks: